Revelation Biosciences

Quarterly Financials

Values in thousands2025-12-312025-09-302025-06-302025-03-31
Revenue
$0
$0
$0
$0
Gross Profit
-5
-6
-7
-7
EBITDA
-2,565
-1,900
-2,454
-2,087
EBIT
-2,571
-1,907
-2,461
-2,094
Net Income
-2,511
-1,907
-2,444
-2,051
Net Change In Cash
0
0
0
0
Free Cash Flow
-1,966
-1,588
-1,919
-2,794
Cash
10,700
12,708
5,173
3,704
Basic Shares
620
2,644
802
971

Annual Financials

Values in thousands2025-12-312024-12-312023-12-312022-12-31
Revenue
$0
$0
$0
$0
Gross Profit
-27
-27
-25
-40
EBITDA
-9,043
-7,947
-8,631
-10,839
EBIT
-9,070
-7,975
-8,656
-10,864
Net Income
-8,913
-15,038
-120
-10,829
Net Change In Cash
0
0
0
0
Free Cash Flow
-8,269
-18,340
-7,286
-11,219
Cash
10,700
6,499
11,991
5,252
Basic Shares
620
171
14
17

Earnings Calls

QuarterEPS
2025-12-31
-$1.65
2025-09-30
-$1.77
2025-06-30
-$7.01
2025-03-31
-$2.11